Filing Details

Accession Number:
0001225208-24-001652
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-06 21:02:55
Reporting Period:
2024-02-02
Accepted Time:
2024-02-06 21:02:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739940 Cigna Group CI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1710190 P Eric Palmer 900 Cottage Grove Road
Bloomfield CT 06002
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2024-02-02 5,684 $139.22 51,248 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2024-02-02 5,684 $325.00 45,564 No 4 S Direct
Common Stock, $.01 Par Value Acquisiton 2024-02-05 1,017 $139.22 46,581 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.01 Par Value Employee Stock Option (Right to Buy) Disposition 2024-02-02 5,684 $0.00 5,684 $139.22
Common Stock, $.01 Par Value Employee Stock Option (Right to Buy) Disposition 2024-02-05 1,017 $0.00 1,017 $139.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,017 2017-03-01 2026-03-01 No 4 M Direct
0 2017-03-01 2026-03-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $.01 Par Value 245 Indirect By 401(k)
Common Stock, $.01 Par Value 41 Indirect By Spouse's 401(k)
Common Stock, $.01 Par Value 1,125 Indirect By Trust
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
  3. This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.